Owing to its expression in many cancer types, various treatments targeting Tn‐MUC1, including chimeric antigen receptor‐T cells (CAR‐T) [50, 51, 52, 53] and vaccines, have been developed [54, 55, 56]. Here, MUC1 is linked to cancer.